Skip to main content
OpenTrials
Completed

NCT Number: NCT03093038

Early Stability of the Delta-TT Cup With Polyethylene Insert Versus a Ceramic Insert. A RSA Study.

The goal of this study is to study the stability of the Delta-TT cup with polyethylene insert and the Delta-TT cup with ceramic insert both combined with the H-MAX femoral stem by means of RSA to assess whether the differences in stiffness of the cup will have an influence on incorporation and mechanical stability.

It is hypothesized that there will be more micromotion on the short-term (<2 years) in the patients with the ceramic insert because of the higher stiffness, however, all components will be considered stable on the short and long-term.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Onze Lieve Vrouwe Gasthuis

Amsterdam, North Holland, 1090 HM, Netherlands

About this study

Rationale: Roentgen Stereophotogrammetric Analysis (RSA) is a very accurate measurement technique used to obtain micromotion of the implants relative to inserted tantalum markers in the surrounding bone. Using RSA, long-term predictions of prosthetic loosening can be made based on a two years follow-up. Therefore, it is recommended to analyse all (new) prosthetic components by means of RSA.

Objective: The goal of this study is to study in a randomised trial the stability of the Delta-TT cup with polyethylene insert and the Delta-TT cup with ceramic insert both combined with the H-MAX femoral stem by means of RSA to assess whether the differences in stiffness of the cup will have an influence on incorporation and mechanical stability. It is hypothesized that there will be more micromotion on the short-term (<2 years) in the patients with the ceramic insert because of the higher stiffness, however, all components will be considered stable on the short and long-term. Secondary goal is to compare the stability of the C2 femoral stem, to the H-MAX femoral stem as well as to compare it to relevant migration results of similar stems from the literature. These RSA results will contribute to knowledge about the early stability and long-term prosthetic loosening of these cementless stems.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled to undergo primary total hip replacement.
  • Patient is able to understand the meaning of the study and is willing to sign the ethical committee approved, study-specific Informed Patient Consent Form.
  • Ability and willingness to follow instructions and to return for follow-up evaluations.
  • The subject is a male or non-pregnant female between 18 and 75 years of age.

Exclusion criteria

  • The subject is morbidly obese, defined as Body Mass Index (BMI) of > 40.
  • The subject will be operated bilaterally.
  • Patients having a deformity or disease located in other joints than the hip that needs surgery and is limiting their ability to walk.
  • The subject has an active or suspected latent infection in or about the hip joint.
  • The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • The subject has a systemic or metabolic disorder leading to progressive bone deterioration.
  • The subject's bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis.
  • Female patients planning a pregnancy during the course of the study.
  • The patient is unable or unwilling to sign the Informed Consent specific to this study.
  • Subject deemed unsuitable for participation in the study based on the investigator's judgement.

Treatment and study plan

H-MAX stem & Delta-TT cup + polyethylene

Device

H-MAX femoral stem & Delta-TT cup with a polyethylene insert

H-MAX stem & Delta-TT cup + ceramic

Device

H-MAX femoral stem & Delta Delta-TT cup with a Ceramic insert

C2 stem & Delta-TT cup + ceramic

Device

C2 femoral stem Delta Delta-TT cup with a Ceramic insert

Primary outcomes

  1. Change from Baseline in stability

    Time frame: 2 years

    Stability will be assessed with Roentgen Stereophotogrammetric Analysis (RSA). RSA will be used to determine the micromotion of the femur and cup components with respect to the bone.The RSA data of the components will be described in terms of translational and rotational movements.

Secondary outcomes

  1. Change from Baseline in Quality of Life

    Time frame: 2 years

    Quality of Life (QoL) will be assessed with the questionaire EuroQoL 5D (EQ- 5D)

  2. Change from Baseline in Quality of Life

    Time frame: 5 years

    Quality of Life (QoL) will be assessed with the questionaire EuroQoL 5D (EQ- 5D)

  3. Change from Baseline in Physical Function

    Time frame: 2 years

    Physical Function will be assessed with the Hip disability and Osteoarthritis Outcome Score - Physical Function Short Form (HOOS-PS)

  4. Change from Baseline in Physical Function

    Time frame: 5 years

    Physical Function will be assessed with the Hip disability and Osteoarthritis Outcome Score - Physical Function Short Form (HOOS-PS)

  5. Change from Baseline in Physical Function and Pain

    Time frame: 2 years

    Physical Function will be assessed with the Oxford Hip Score (OHS)

  6. Change from Baseline in Physical Function and Pain

    Time frame: 5 years

    Physical Function will be assessed with the Oxford Hip Score (OHS)

  7. Change from Baseline in Pain

    Time frame: 2 years

    Pain will be assessed with a Numeric Rating Scale (NRS)

  8. Change from Baseline in Pain

    Time frame: 5 years

    Pain will be assessed with a Numeric Rating Scale (NRS)

Sponsors and collaborators

Lead sponsor

JointResearch

Other

Registry information

Official study title

Early Stability of the Delta-TT Cup With Polyethylene Insert Compared to the Delta-TT Cup With Ceramic Insert. A Randomised RSA Study

Acronym: RSA-DELTA-TT

Important dates

Study start
2014
Primary completion
2018
Study completion
2021
First posted
Mar 28, 2017
Registry last updated
Oct 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.